Nor Azian Abdul Murad, PhD

Dr Nor Azian Abdul Murad graduated with Bachelor Science (Biomedical Science) from UPM in 1999, MSc (Medical Sciences) from UKM in 2004 and PhD (Clinical Medicine) from the University of Queensland, Australia in 2011. Currently, she is a Research fellow and Head of Quality Assurance in UMBI since October 2016. Her research interests include non-communicable diseases (NCD) such as diabetes and hypercholesterolemia, rare diseases and neurodegenerative diseases such as Parkinson’s disease. Currently, her work focuses on identification of mutations or variants involved in these diseases using whole exome sequencing, targeted sequencing and genotyping using mass spectrometry. In addition, she also studied the genetic-environmental association related to NCD and rare diseases. Her previous PhD work focuses on mitochondrial functions and also oxidative stress in a very rare ataxia case known as Ataxia Oculomotor Apraxia type 3 (AOA3). She is approved signatory for HLA-B:1502 and β-thalassemia testing under MS ISO/IEC 17025:2005 (scope: acid nucleic) in UMBI since 2011. She received several grants namely FRGS, GGPM, GUP from the MOSTI and UKM from 2011 – 2015.